WO2026042013 - MITOCHONDRIAL THERAPY
National phase entry is expected:
Publication Number
WO/2026/042013
Publication Date
26.02.2026
International Application No.
PCT/IB2025/058371
International Filing Date
18.08.2025
Title **
[English]
MITOCHONDRIAL THERAPY
[French]
THÉRAPIE MITOCHONDRIALE
Applicants **
INSTITUTE OF MOLECULAR AND CLINICAL OPHTHALMOLOGY BASEL (IOB)
Inventors
AYUPOV, Temurkhan
ROSKA, Botond Miklós
MORENO JUAN, Verónica de la Santísima Faz
HANSEN, Simon Theodor
Priority Data
63/684,592
19.08.2024
US
63/711,933
25.10.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7406 | |
| EPO | Filing, Examination, Granting | 68962 | |
| Japan | Filing, Examination, Granting | 4007 | |
| South Korea | Filing, Examination, Granting | 5877 | |
| USA | Filing, Examination, Granting | 32090 |
Total:
118,342
Contact Us
Abstract[English]
The disclosure relates to compositions and methods for mitochondrial transplantation into desired cells. Molecular binders and methods described herein can provide cell type targeted delivery and transplantation of mitochondria with increased efficiency and specificity.[French]
La divulgation concerne des compositions et des procédés de transplantation mitochondriale dans des cellules souhaitées. Les liants moléculaires et les procédés décrits dans la description peuvent assurer une administration ciblée de type cellulaire et une transplantation de mitochondries avec une efficacité et une spécificité accrues.